These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 37619891)

  • 41. Dorsolateral subthalamic neuronal activity enhanced by median nerve stimulation characterizes Parkinson's disease during deep brain stimulation with general anesthesia.
    Tsai ST; Chuang WY; Kuo CC; Chao PC; Chen TY; Hung HY; Chen SY
    J Neurosurg; 2015 Dec; 123(6):1394-400. PubMed ID: 26024004
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A new biomarker for subthalamic deep brain stimulation for patients with advanced Parkinson's disease--a pilot study.
    Gmel GE; Hamilton TJ; Obradovic M; Gorman RB; Single PS; Chenery HJ; Coyne T; Silburn PA; Parker JL
    J Neural Eng; 2015 Dec; 12(6):066013. PubMed ID: 26469805
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical outcomes following awake and asleep deep brain stimulation for Parkinson disease.
    Chen T; Mirzadeh Z; Chapple KM; Lambert M; Shill HA; Moguel-Cobos G; Tröster AI; Dhall R; Ponce FA
    J Neurosurg; 2018 Mar; 130(1):109-120. PubMed ID: 29547091
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Deep brain stimulation for Parkinson's disease: meta-analysis of results of randomized trials at varying lengths of follow-up.
    Mansouri A; Taslimi S; Badhiwala JH; Witiw CD; Nassiri F; Odekerken VJJ; De Bie RMA; Kalia SK; Hodaie M; Munhoz RP; Fasano A; Lozano AM
    J Neurosurg; 2018 Apr; 128(4):1199-1213. PubMed ID: 28665252
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biophysical basis of subthalamic local field potentials recorded from deep brain stimulation electrodes.
    Maling N; Lempka SF; Blumenfeld Z; Bronte-Stewart H; McIntyre CC
    J Neurophysiol; 2018 Oct; 120(4):1932-1944. PubMed ID: 30020838
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correspondence of optimal stimulation and beta power varies regionally in STN DBS for Parkinson disease.
    Lu CW; Chou KL; Patil PG
    Parkinsonism Relat Disord; 2020 Sep; 78():124-128. PubMed ID: 32814231
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dopamine transporter imaging predicts motor responsiveness to levodopa challenge in patients with Parkinson's disease: A pilot study of DATSCAN for subthalamic deep brain stimulation.
    Nakajima A; Shimo Y; Sekimoto S; Kamagata K; Jo T; Oyama G; Umemura A; Hattori N
    J Neurol Sci; 2018 Feb; 385():134-139. PubMed ID: 29406893
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Use of Image Guided Programming to Improve Deep Brain Stimulation Workflows with Directional Leads in Parkinson's Disease.
    Rolland AS; Touzet G; Carriere N; Mutez E; Kreisler A; Simonin C; Kuchcinski G; Chalhoub N; Pruvo JP; Defebvre L; Reyns N; Devos D; Moreau C
    J Parkinsons Dis; 2024; 14(1):111-119. PubMed ID: 38189764
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of deep brain stimulation of the subthalamic nucleus on freezing of gait in Parkinson's disease: a prospective controlled study.
    Vercruysse S; Vandenberghe W; Münks L; Nuttin B; Devos H; Nieuwboer A
    J Neurol Neurosurg Psychiatry; 2014 Aug; 85(8):871-7. PubMed ID: 24396010
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial.
    Odekerken VJ; van Laar T; Staal MJ; Mosch A; Hoffmann CF; Nijssen PC; Beute GN; van Vugt JP; Lenders MW; Contarino MF; Mink MS; Bour LJ; van den Munckhof P; Schmand BA; de Haan RJ; Schuurman PR; de Bie RM
    Lancet Neurol; 2013 Jan; 12(1):37-44. PubMed ID: 23168021
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Subthalamic nucleus deep brain stimulation with a multiple independent constant current-controlled device in Parkinson's disease (INTREPID): a multicentre, double-blind, randomised, sham-controlled study.
    Vitek JL; Jain R; Chen L; Tröster AI; Schrock LE; House PA; Giroux ML; Hebb AO; Farris SM; Whiting DM; Leichliter TA; Ostrem JL; San Luciano M; Galifianakis N; Verhagen Metman L; Sani S; Karl JA; Siddiqui MS; Tatter SB; Ul Haq I; Machado AG; Gostkowski M; Tagliati M; Mamelak AN; Okun MS; Foote KD; Moguel-Cobos G; Ponce FA; Pahwa R; Nazzaro JM; Buetefisch CM; Gross RE; Luca CC; Jagid JR; Revuelta GJ; Takacs I; Pourfar MH; Mogilner AY; Duker AP; Mandybur GT; Rosenow JM; Cooper SE; Park MC; Khandhar SM; Sedrak M; Phibbs FT; Pilitsis JG; Uitti RJ; Starr PA
    Lancet Neurol; 2020 Jun; 19(6):491-501. PubMed ID: 32470421
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease.
    Ostrem JL; Ziman N; Galifianakis NB; Starr PA; Luciano MS; Katz M; Racine CA; Martin AJ; Markun LC; Larson PS
    J Neurosurg; 2016 Apr; 124(4):908-16. PubMed ID: 26495947
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Programming Algorithm for the Management of Speech Impairment in Subthalamic Nucleus Deep Brain Stimulation for Parkinson's Disease.
    Swinnen BEKS; Lotfalla V; Scholten MN; Prins RHN; Goes KM; de Vries S; Geytenbeek JJM; Dijk JM; Odekerken VJ; Bot M; van den Munckhof P; Schuurman PR; de Bie RMA; Beudel M
    Neuromodulation; 2024 Apr; 27(3):528-537. PubMed ID: 37452799
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Simultaneous low-frequency deep brain stimulation of the substantia nigra pars reticulata and high-frequency stimulation of the subthalamic nucleus to treat levodopa unresponsive freezing of gait in Parkinson's disease: A pilot study.
    Valldeoriola F; Muñoz E; Rumià J; Roldán P; Cámara A; Compta Y; Martí MJ; Tolosa E
    Parkinsonism Relat Disord; 2019 Mar; 60():153-157. PubMed ID: 30241951
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Value of subthalamic nucleus local field potentials recordings in predicting stimulation parameters for deep brain stimulation in Parkinson's disease.
    Yoshida F; Martinez-Torres I; Pogosyan A; Holl E; Petersen E; Chen CC; Foltynie T; Limousin P; Zrinzo LU; Hariz MI; Brown P
    J Neurol Neurosurg Psychiatry; 2010 Aug; 81(8):885-9. PubMed ID: 20466699
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Directional Recording of Subthalamic Spectral Power Densities in Parkinson's Disease and the Effect of Steering Deep Brain Stimulation.
    Bour LJ; Lourens MA; Verhagen R; de Bie RM; van den Munckhof P; Schuurman PR; Contarino MF
    Brain Stimul; 2015; 8(4):730-41. PubMed ID: 25753176
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Subthalamic deep brain stimulation and trunk posture in Parkinson's disease.
    Artusi CA; Zibetti M; Romagnolo A; Rizzone MG; Merola A; Lopiano L
    Acta Neurol Scand; 2018 May; 137(5):481-487. PubMed ID: 29285760
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The subthalamic activity and striatal monoamine are modulated by subthalamic stimulation.
    Yamamoto T; Uchiyama T; Sakakibara R; Taniguchi J; Kuwabara S
    Neuroscience; 2014 Feb; 259():43-52. PubMed ID: 24291727
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease.
    Anderson VC; Burchiel KJ; Hogarth P; Favre J; Hammerstad JP
    Arch Neurol; 2005 Apr; 62(4):554-60. PubMed ID: 15824252
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Theta-alpha oscillations characterize emotional subregion in the human ventral subthalamic nucleus.
    Rappel P; Grosberg S; Arkadir D; Linetsky E; Abu Snineh M; Bick AS; Tamir I; Valsky D; Marmor O; Abo Foul Y; Peled O; Gilad M; Daudi C; Ben-Naim S; Bergman H; Israel Z; Eitan R
    Mov Disord; 2020 Feb; 35(2):337-343. PubMed ID: 31758821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.